KCNK1 encodes a potassium channel with somewhat poorly-defined physiologic roles in both the heart and the brain [16] and has been identified as a potential prognostic biomarker and therapeutic target in breast cancer [17]. Here, KCNA3 is linked to breast carcinoma.